Discover

NAUT
Nautilus Biotechnology, Inc.
2.06
5 x 2.05
2 x 2.63
bid
ask
-
0.10
4.63%
4 @ 04:00 PM
2.07 +0.01 (0.46%)
Ytd5.64%
1y92.52%
1.99
day range
2.23
0.84
52 week range
4.31
Open2.17Prev Close2.16Low1.99High2.23Mkt Cap261.78M
Vol6.40MAvg Vol3.49MEPS-0.45P/EN/AForward P/E-2.32
Beta1.04Short Ratio9.26Inst. Own50.19%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning10-2750-d Avg1.18200-d Avg2.081yr Est3.44
Income Statement
Total Revenue190.00K
Revenues (USD)190.00K
Cost of Revenue15.00K
Gross Profit175.00K
Operating Expenses15.94M
Research and Development Expense9.61M
Selling, General and Administrative Expense6.33M
Operating Income-15.76M
Net Income-14.47M
Net Income Common Stock-14.47M
Net Income Common Stock (USD)-14.47M
Consolidated Income-14.47M
Earnings per Basic Share-0.11
Earnings per Basic Share (USD)-0.11
Earnings per Diluted Share-0.11
Earning Before Interest & Taxes (EBIT)-14.47M
Earning Before Interest & Taxes (USD)-14.47M
Weighted Average Shares127.14M
Weighted Average Shares Diluted127.14M
Balance Sheet
Cash and Equivalents13.17M
Cash and Equivalents (USD)13.17M
Investments116.02M
Investments Current70.86M
Investments Non-Current45.16M
Current Assets87.63M
Property, Plant & Equipment Net29.62M
Total Assets163.58M
Debt Current3.99M
Total Debt27.82M
Current Liabilities8.64M
Debt Non-Current23.83M
Total Liabilities32.46M
Accumulated Retained Earnings (Deficit)-361.19M
Accumulated Other Comprehensive Income-331.00K
Shareholders Equity131.11M
Shareholders Equity (USD)131.11M
Assets Non-Current75.95M
Total Debt (USD)27.82M
Liabilities Non-Current23.83M
Trade and Non-Trade Payables1.10M
Cash Flow
Depreciation, Amortization & Accretion1.28M
Net Cash Flow from Financing244.00K
Net Cash Flow / Change in Cash & Cash Equivalents-1.46M
Capital Expenditure-454.00K
Issuance (Purchase) of Equity Shares244.00K
Net Cash Flow from Investing12.02M
Net Cash Flow - Investment Acquisitions and Disposals12.48M
Net Cash Flow from Operations-13.73M
Share Based Compensation1.16M